At P95, we are dedicated to making a significant impact on global health through our therapeutic expertise in vaccines and infectious diseases. Our commitment to innovation and excellence has positioned us as leaders in this critical field.
Our teams are structured into four specialized therapeutic programs—Viral, Bacterial, Global, and Non-Communicable Diseases (NCD). With over 300 vaccine and infectious disease projects in recent years, including 75% in vaccines alone, each program is staffed with experts who bring unparalleled knowledge and experience in their respective areas. Backed by 300 staff globally, our multidisciplinary approach ensures that we deliver the highest level of expertise and tailored solutions for every project.
By integrating our specialized skills with a passion for improving lives, P95 is at the forefront of delivering impactful solutions that make a real difference in communities worldwide.
%
Viral Diseases
viral diseases
Our viral program is dedicated to a wide range of viral diseases, with particular specialization in burden of disease and vaccine effectiveness studies. We have extensive experience in retrospective and prospective data collection across a range of populations, from adults to children, and in a variety of settings, including primary care, hospitals, and intensive care units.
We have experience in viral diseases including:
-
COVID-19
-
Influenza
-
RSV
-
Polio
-
Varicella
-
Herpes zoster
-
HIV
-
HPV
-
Hepatitis
-
Rabies
%
bacterial Diseases
Bacterial Diseases
Our Bacterial Program focuses on combating bacterial infections. We leverage our extensive expertise and innovative approaches to develop effective vaccines and treatments. Our multidisciplinary team works tirelessly to address a wide range of bacterial pathogens, ensuring that we provide tailored solutions for each challenge.
We have experience in bacterial diseases, including those caused by:
- Escherichia coli
- Borrelia spp (Lyme disease)
- Bordetella pertussis (Pertussis)
- Group B Streptococcus
- Neisseria meningitidis (Meningococcal disease)
- Steptococcus pneumoniae (Pneumococcal disease)
%
global Diseases
global diseases
We are uniquely placed with staff on the ground in regions where there are outbreaks, supporting pandemic preparedness and rapid response, and study implementation in outbreak settings
Our experience in global diseases includes:
- Dengue
- Chikungunya
- Lassa fever
- Norovirus
- Malaria
- HIV
%
Non-Communicable Diseases
Non-Communicable Diseases (NCD)
Our NCD Program expands beyond vaccines and infectious diseases to addressing non-communicable diseases worldwide. Our experience includes chronic conditions, such as cardiovascular diseases, diabetes, cancer, and respiratory diseases, which pose significant health challenges and require innovative solutions. At P95, we are committed to developing and implementing strategies that prevent and manage these diseases effectively. Our multidisciplinary team combines scientific rigor with a genuine passion for improving health outcomes, ensuring that we provide impactful solutions that enhance the quality of life for individuals affected by NCDs.
Our therapeutic experience includes:
- Oncology
- Pneumology
- Cardiology
- Dermatology
- Gastroenterology
- Maternal care
- Pediatrics and neonatal care
- Rare diseases